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Abstract
Background: Methanol extract of Bauhinia purpurea L. (family Fabaceae) (MEBP) possesses high antioxidant and
anti-inflammatory activities and recently reported to exert hepatoprotection against paracetamol (PCM)-induced
liver injury in rats. In an attempt to identify the hepatoprotective bioactive compounds in MEBP, the extract was
prepared in different partitions and subjected to the PCM-induced liver injury model in rats.
Methods: Dried MEBP was partitioned successively to obtain petroleum ether (PEBP), ethylacetate (EABP) and
aqueous (AQBP) partitions, respectively. All partitions were subjected to in vitro antioxidant (i.e. total phenolic
content (TPC), 2,2-diphenyl-1-picrylhydrazyl (DPPH)- and superoxide-radicals scavenging assay, and oxygen radical
absorbance capacity (ORAC) assay) and anti-inflammatory (i.e. lipooxygenase (LOX) and xanthine oxidase (XO) assay)
analysis. The partitions, prepared in the dose range of 50, 250 and 500 mg/kg, together with a vehicle (10 % DMSO)
and standard drug (200 mg/kg silymarin) were administered orally for 7 consecutive days prior to subjection to the
3 mg/kg PCM-induced liver injury model in rats. Following the hepatic injury induction, blood samples and liver
were collected for the respective biochemical parameter and histopathological studies. Body weight changes and
liver weight were also recorded. The partitions were also subjected to the phytochemical screening and HPLC
analysis.
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Results: Of all partitions, EABP possessed high TPC value and demonstrated remarkable antioxidant activity when
assessed using the DPPH- and superoxide-radical scavenging assay, as well as ORAC assay, which was followed by
AQBP and PEBP. All partitions also showed low anti-inflammatory activity via the LOX and XO pathways. In the
hepatoprotective study, the effectiveness of the partitions is in the order of EABP>AQBP>PEBP, which is supported
by the microscopic analysis and histopathological scoring. In the biochemical analysis, EABP also exerted the most
effective effect by reducing the serum level of alanine transaminase (ALT) and aspartate transaminase (AST) at all
doses tested in comparison to the other partitions. Phytochemical screening and HPLC analysis suggested the
presence of: flavonoids, condensed tannins and triterpenes in EABP; flavonoids, condensed tannins and saponins in
PEBP and; only saponins in AQBP.
Conclusion: EABP demonstrates the most effective hepatoprotection against PCM-induced liver injury in rats. This
observation could be attributed to its remarkable antioxidant activity and the presence of flavonoids that might
probably act synergistically with other biocompounds to cause the hepatoprotection.
Keywords: Bauhinia purpurea, Fabaceae, Hepatoprotection, Antioxidant, Flavonoids, Synergistic action
Background
One of the most widely used drugs prescribed for liver
treatment to counteract poisoning by the well-known
over-the-counter analgesic (i.e.paracetamol; PCM) is N-
Acetylcysteine (NAC). The use of NAC as an antioxidant
to effectively replenish glutathione (GSH) intracellular
stores in the circulatory system has demonstrated en-
couraging results in animal models of reperfusion injur-
ies and ischemia, and it has been consumed by humans
for several years [1]. However, the effectiveness of NAC
has been surpassed by several reports on its adverse ef-
fects on health [2]. Due to this problem, there is still a
need to search for alternative agents for the treatment of
liver ailments with less or, possibly, no side effects,
cheaper and widely available. Plants have been one of
the good sources of new bioactive compounds [3] and,
interestingly, Malaysia, with its rich flora and fauna, have
been one of the countries that supported researches re-
lated to natural product-based drug discoveries [4].
In an attempt to contribute to the field of natural
product-related drug discoveries, we have exploited sev-
eral plants wildly cultivated in Malaysia but considered
previously to be neglected and underutilized plants [5].
One of the plants is Bauhinia purpurea L., which be-
longs to the family Fabaceae. Locally known as ‘Tapak
Kerbau’, this plant is native to Malaysia but no trad-
itional medicinal use has been recorded among the
Malay tribes. However, B. purpurea has medicinal values
to the peoples in the Indian region wherein it is used to
treat ulcer wounds, stomach tumors, fever, diarrhea and
glandular swellings [6]. Through scientific studies, vari-
ous pharmacological potentials of B. purpurea have been
reported such as antioxidant [7, 8, 9], antiulcer [10,
11], anti-inflammatory [7, 12, 13], antinociceptive, anti-
pyretic [13, 14, 15], antiproliferative [9], antimicrobial
[16], and wound healing [17]. In addition to these, we
have recently reported on the hepatoprotective activity
of methanol extract of B. purpurea leaves against the
carbon tetrachloride (CCl4)-induced liver toxicity model
[6]. The mechanisms of hepatotoxicity induced by CCl4
differ from other agents such as paracetamol (PCM)
[18]. Based on previous reports on the overuse of PCM
and its adverse side effects [2] and that its mechanism of
hepatotoxicity differs from CCl4, there is a need to find
alternative cure to PCM-induced hepatotoxicity. There-
fore, the present study was proposed to study the parti-
tions of methanol extract of B. purpurea leaves (MEBP)




Methanol, petroleum ether, and ethyl acetate (Fisher Sci-
entific UK, Loughborough), Paracetamol (PCM) and
silymarin (Sigma-Aldrich, USA) were used in the present
study. All other chemicals and reagents used were of
analytical grade.
Collection of plant material
The leaves of B. purpurea were collected around Univer-
siti Putra Malaysia (UPM), Serdang, Selangor, Malaysia.
A voucher specimen (SK 1985/11) was identified by
comparison with specimens available at the Herbarium
of the Laboratory of Natural Products, Institute of Bio-
science, UPM. The leaves were dried under shade for
7 days at room temperature, segregated, and pulverized
by mechanical grinder to form a coarse powder.
Preparation of methanol extract of B. purpurea (MEBP)
The coarse powder of B. purpurea (1 kg) was macerated
in 20 L methanol (ratio of 1:20 (w/v) was used) for 72 h.
The supernatant was collected and filtered sequentially
using cloth filter, cotton wool and Whatman No. 1 filter
paper followed by evaporation (Buchi Rotavapor® R210/
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215, Switzerland) under reduced pressure (204 mbar)
and controlled temperature (40 °C). The plant residue
was collected and subjected to the similar extraction
process for another two times.
Preparation of petroleum ether, ethyl acetate and
aqueous partitions from MEBP
Petroleum ether, ethyl acetate, and aqueous extraction of
MEBP were achieved by the standard solvent partition-
ing methods described by Balan et al. [19] with slight
modifications. MEBP (2 g) was dissolved in 100 mL
methanol and 200 mL distilled water. The solution (suspen-
sion) was partitioned accordingly as 3 × 700 mL petroleum
ether and 3 × 700 mL ethyl acetate, successively, yielding
the aqueous partition at the end of the process. The 2-
phase immiscible liquid solutions, obtained during each of
the petroleum ether or ethyl acetate partitioning, were
separated after 30 min. The solvent was then evaporated
under reduced pressure (204 Mbar) and controlled
temperature (40 °C) using a vacuum rotary evaporator
(Buchi Rotavapor® R210/215, Switzerland); the aqueous
extract was then subjected to the freeze-drying process.
Antioxidant activity of PEBP, EABP and AQBP
Total phenolic content
Determination of total phenolic content (TPC) was per-
formed using Folin-Ciocalteu reagent according to the
method of Singleton and Rossi [20] with slight modifica-
tions. Briefly, 1.0 mg of the respective partition was ex-
tracted for 2 h with 1.0 mL 80 % methanol containing
1.0 % hydrochloric acid and 1.0 % distilled water at room
temperature on a shaker at 200 rpm. The mixture was
centrifuged at 6000 rpm for 15 min and the supernatant
was decanted into vials. The supernatant was used for
the determination of TPC. The supernatant extract
(200 μL) was mixed with 400 μL Folin-Ciocalteu reagent
(0.1 mL/0.9 mL) and allowed to stand at room
temperature for 5 min. Then, 400 μL sodium bicarbonate
(60.0 mg/mL) solution was added, and the mixture was
allowed to stand at room temperature for 90 min. Absorb-
ance was measured at 725 nm. A calibration curve was
generated by using the optical density (OD) of the gallic
acid (GA) standard, and the levels in the samples were
expressed as GA equivalent (GAE)-TPC mg/100 g.
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
assay
The antioxidant reducing activity of each partition on
DPPH radicals was estimated according to the method
of Blois [21] with modifications involving the use of a
high-throughput microplate system. Sample (50 μL of
1.0 mg/mL) was added to 50 μL DPPH (FG: 384.32)
(1 mM in ethanolic solution) and 150 μL ethanol (abso-
lute) in a 96-well microtiter plate in triplicate. The plate
was shaken (15 s, 500 rpm) and left to stand at room
temperature for 30 min. The absorbance of the resulting
solution was measured spectrophotometrically at
520 nm. Data were analyzed using GraphPad PRISM®
V5.01 (GraphPad Software, La Jolla, CA, USA). The IC50
was determined from an overdose–response curve. The
IC50 of a sample can be determined by constructing a
dose–response curve and examining the effect of differ-
ent concentrations, namely 3.13, 6.25, 25, 50, and
200 μg/mL.
Xanthine/xanthine oxidase (X/XOD) superoxide scavenging
assay
The assay was performed according to the method of
Subramaniam et al. [22] with slight modifications. Nitro-
blue tetrazolium (NBT) solution (100 mL of 4.1 mM/L)
was prepared by adding 3.15 g Tris–HCl, 0.1 g MgCl2,
15.0 mg 5-bromo-4-chloro-3-indolyl phosphate, and
34.0 mg 4-NBT chloride to 100 mL distilled water. The
reaction mixture (100 mL) was prepared by dissolving
0.53 g Na2CO3 (pH 10.2), 4.0 mg EDTA, and 2.0 mg
xanthine in 0.025 mM NBT solution. The mixture was
kept refrigerated at 4 °C. For the negative control group,
approximately 999 uL of the reaction mixture was trans-
ferred into a microcuvette and placed in a cell holder of
a spectrophotometer maintained at 25 °C. This was
followed by the addition of 1x10−3 U/ml of xanthine oxi-
dase (XOD) to initiate the generation of superoxide for-
mation. The optical density (OD) measurements were
taken at 560 nm for 120 s using a Lambda 2S spectro-
photometer. For the positive control group, approxi-
mately 979 uL of the reaction mixture was transferred
into a microcuvette and placed in a 25 °C cell holder of
a spectrophotometer. Then 1.16U/mL of superoxide dis-
mutase (SOD) was added into the reaction mixture and
thoroughly mixed. XOD (1x10-3 U/mL) was then added
to start the generation of superoxide formation. OD was
taken at 560 nm for 120 s at intervals of 10 s. For the
treatment group, approximately 5 uL of the respective
200 ug/mL PEBP, EABP or AQBP, were dissolved in ap-
proximately 994 uL of the reaction mixture that was
placed in a cell holder of a spectrophotometer main-
tained at 25 °C. XOD (1x10−3 U/ml) was then added and
after thoroughly mixing, similarly measured for the
XOD and SOD curves.
Oxygen radical absorbance capacity (ORAC) test
The oxygen radical absorbance capacity (ORAC) test
was carried out according to Huang et al. [23] with
slight modifications. 2,2’-Azobis(2-methylpropionami-
dine) dihydrochloride (AAPH) (0.65 g) was dissolved in
10 mL 75 mM phosphate buffer (pH 7.4) to a concentra-
tion of 240 mM, and was freshly made. A fluorescein
stock solution (1 mM) was prepared in 75 mM
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phosphate buffer (pH 7.4), wrapped in foil, and stored at
5 °C. Immediately before use, the stock solution was di-
luted with 75 mM phosphate buffer at 1:100,000. The di-
luted sodium fluorescein was prepared daily as a fresh
solution. The sodium fluorescein solution (150 mL) was
placed in the interior experimental wells. The blanks
contained 25 mL Trolox dilution. The sample wells con-
tained 25 mL sample. The plate was then incubated for
10 min at 37 °C for equilibration. BMG Omega Fluostar
Fluorescent Spectrophotometer (BMG LABTECH,
Germany) with injector using an emission filter of 528-
nm bandpass and excitation filter of 485-nm bandpass
was used. The plate reader was analyzed using MARS
Data Analysis software (BMG LABTECH, Germany).
AAPH solution (25 mL, 240 mM) was added using the
injector of the microplate reader to a final volume of
200 mL to start the reaction. The 25 mL AAPH solution
was then mixed by shaking for 50 s at maximum inten-
sity. The fluorescence was observed kinetically, with data
recorded every minute. The reading of the fluorescence
of each well was measured every 60 s. ORAC values
were analyzed using MARS Data Analysis Reduction
software (BMG LABTECH, Germany). All assays were
performed in three independent replicates.
Anti-Inflammatory assays
Lipoxygenase assay
Lipoxygenase (LOX)-inhibiting activity was detected
using the spectrophotometric method as described by
Malik et al. [24]. Sodium phosphate buffer (160 mL,
0.1 M, pH 8.0), 20 mL soybean LOX solution, and
10 mL of each partition were mixed and incubated at
25 °C for 10 min. The reactions were initiated by the
addition of 10 mL substrate in the form of sodium lino-
leic acid solution. The enzymatic conversion of linoleic
acid to form (9Z, 11E)-(13S)-13-hydroperoxyoctadeca-
9,11-dienoate causes the change in absorbance measured
at 234 nm over a period of 6 min. The reference stand-
ard, nordihydroguaiaretic acid (NDGA) and partitions
were dissolved in methanol. All reactions were per-
formed in triplicate in a 96-well microplate.
Xanthine oxidase assay
The procedure was carried out according to the spec-
trophotometric method described by Noro et al. [25]
to measure the activity of the partitions in xanthine
oxidase (XO) inhibition. XO solution (10 μL), 130 μL
potassium phosphate buffer (0.05 M, pH 7.5), and
10 μL of test extracts were mixed together and incubated
at 25 °C for 10 min. The reaction started after the addition
of 100 μL substrate in the form of xanthine solution. The
conversion from xanthine to hydrogen peroxide and uric
acid was measured at 295 nm. The reference standard,
Allopurinol and tested extracts were dissolved in DMSO.
All reactions were completed in a 96-well UV microplate
in triplicate.
Experimental animals
The study protocol of the present study was approved
by the Animal Care and Use Committee (ACUC), Fac-
ulty of Medicine and Health Sciences, UPM (Ethical ap-
proval no.: UPM/FPSK/PADS/BR-UUH/00450). Male
Sprague Dawley rats (180–200 g; 8–10 weeks old) were
obtained from the Veterinary Animal Unit, Faculty of
Veterinary Medicine, Universiti Putra Malaysia (UPM),
Malaysia and were house at room temperature (27 ± 2 °
C; 70 – 80 % humidity; 12 h light/darkness cycle) in the
Animal Holding Unit (UPM). They were supplied with
food and water ad libitum from the beginning of the ex-
periments. The rats were handled in accordance with
current UPM guidelines for the care of laboratory ani-
mals and the ethical guidelines for investigations of ex-
perimental pain in conscious animals. All experiments
were conducted between 09.30 and 18.30 h to minimize
the effects of environmental changes.
Hepatoprotective assay
The in vivo hepatoprotective activity of PEBP, EABP and
AQBP were determined using PCM-induced hepatotox-
icity in rats. As described in Table 1, the groups were
assigned and administered with the respective test solu-
tions. The procedures for PCM were carried out accord-
ing to Porchezhian and Ansari [26]. The animals were
fasted for 48 h prior to the experiment under standard
laboratory conditions. After 48 h, each group of rats re-
ceived the respective dose of test solution orally once
daily for 7 consecutive days. The administration of PCM
(3 mg/kg, p.o) was performed 3 h after the last dose of
each partition administration on day 7, except for group
I, which received only 10 % dimethyl sulfoxide (DMSO).
Table 1 PCM-induced hepatotoxicity treatment groups of the
extracts
Group Extracts Doses of extracts
I. Normal control: 10 % DMSO, p.o
II. Negative control: 10 % DMSO, p.o
Ill. Positive control: 200 mg/kg silymarin, p.o
IV. PEBP 50 mg/kg PEBP, p.o
V. 250 mg/kg PEBP, p.o
VI. 500 mg/kg PEBP, p.o
VlI. EABP 50 mg/kg EABP, p.o
VllI. 250 mg/kg EABP, p.o
IX. 500 mg/kg EABP, p.o
X. AQBP 50 mg/kg AQBP, p.o
XI. 250 mg/kg AQBP, p.o
XlI. 500 mg/kg AQBP, p.o
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Forty-eight hours after the hepatic injury induction, the
animals were anesthetized using diethyl ether and blood
samples were obtained via cardiac puncture using a ster-
ile disposable syringe for biochemical parameter study.
The body weights of the animals were measured before
they were sacrificed. Subsequently, the rats were sacrificed
and then the livers were harvested, washed in normal sa-
line, blotted with filter paper, and weighed. Gross examin-
ation was conducted to examine for any abnormalities in
the organ. The livers of all animals were subsequently sub-
jected to antioxidant assays and histopathological
examination.
Biochemical studies
The plasma samples were collected for measuring liver
markers. Biochemical parameters were assayed accord-
ing to standard methods. Alanine transaminase (ALT),
alkaline phosphatase (ALP), aspartate transaminase
(AST), total protein (TP), and lactate dehydrogenase
(LDH) levels were measured using a Hitachi 902 Auto-
matic Chemical Analyser, USA.
Histopathology
The liver tissue was dissected out and fixed in 10 % for-
malin, dehydrated in graded ethanol (50–100 %), cleared
in xylene, and embedded in paraffin wax. The sections,
which were 5–6-μm thick, were then prepared using a
rotary microtome (Leica RM2125 RTS, Singapore) and
stained with hematoxylin and eosin dye for microscopic
observation of histopathological changes in the liver.
Liver sections were then scored and evaluated according
to the severity of the hepatic injury as described by El-
Beshbishy et al. [27].
Phytochemical screening of PEBP, EABP and AQBP
Phytochemical screening of PEBP, EABP and AQBP was
performed according to standard screening tests and
conventional protocols as described in detail by Kamar-
olzaman et al. [28]. The analysis of phytoconstituents in
those partitions was performed to detect alkaloids, flavo-
noids, triterpenes, tannins, saponins and steroids.
HPLC Profiling of PEBP, EABP and AQBP
The HPLC analysis of PEBP, EABP and AQBP was per-
formed according to a previous report [19]. Approxi-
mately, 10 mg of the respective partition was suspended
in 1 ml methanol and then filtered through the mem-
brane filter with a pore size of 0.45 μm. A Waters Delta
600 with 600 Controller and Waters 2996 Photodiode
Array (Milford, MA, USA) equipped with an autosam-
pler, online degasser and column heater was used to
analyze the filtered sample. Data was evaluated and
processed using the installed Millenium 32 Software
(Waters Product). The filtered samples were separated at
27 °C on a minibore Phenomenex Luna 5 μm C18 col-
umn (dimensions 250 x 4.60 mm) using a one-step lin-
ear gradient. Two solvents denoted as A, which is 0.1 %
aqueous formic acid, and B, which is acetonitrile, were
used to elute the constituents. Initial conditions were set
at 95 % A and 5 % B with a linear gradient reaching
25 % B at t = 12 min. This condition was maintained for
8 min before B was reduced back to 15 % at t = 22 min
for another 8 min (t = 30 min). At t = 35 min, the
programme was returned to the initial solvent compos-
ition. The flow rate used was 1.0 ml/min and the injec-
tion volume was 10 μl. The column oven was set at 27 °
C and the eluent was monitored at 210, 254, 280, 300,
330 and 366 nm. The retention times, peak areas and
UV spectra of the major peaks were analyzed.
Statistical analysis
Data obtained are presented in Mean ± Standard Error
of Mean (SEM). The data were analyzed using the one-
way analysis of variance (ANOVA) and the differences
between all partition-treated group were determined
using the Tukeys post-hoc test with P < 0.05 as the limit
of significance.
Result
In vitro antioxidant activity of all fractions
Total phenolic content (TPC) value
Table 2 shows the TPC value of PEBP, EABP, and AQBP
at the concentration of 200 μg/mL. Based on the stand-
ard protocol, compounds with a TPC value that is higher
than 1000 mg GAE/100 g can be considered to have a
high TPC value. Hence, all partitions, which possessed
the TPC value between 100–300 mg/100 g GAE can be
considered as to have low TPC value in the sequence of
EABP > AQBP > PEBP.
DPPH- and superoxide- radical scavenging activities and
ORAC value
PEBP and AQBP, at the concentration of 200 μg/mL,
demonstrated a very low antioxidant activity when
assessed using the DPPH radical scavenging assay with
the recorded percentage of antioxidant of 17.1 and
19.4 %, respectively. On the other hand, 200 μg/mL
EABP showed the highest antioxidant activity (64.6 %)
among the partitions tested, but, overall EABP was con-
sidered to have a moderate antioxidant activity.
Table 2 Total phenolic content of different extracts
Sample Total phenolic content (TPC) mg/100 g GAE
PEBP 104.83 ± 1.64
EABP 270.27 ± 39.06
AQBP 132.08 ± 15.88
Total phenolic content are expressed as GAE (gallic acid equivalent)
All values are expressed as mean ± SEM
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For the superoxide scavenging activity, EABP also
showed the highest percentage of scavenging activity,
followed by PEBP, and AQBP (Table 3).
In the ORAC assay, AQBP had the highest ORAC
value, followed by EABP and PEBP (Table 4).
In vitro anti-inflammatory activity
LOX and XO activities
In both assays, all partitions caused weak inhibition of
LOX and XO activities at the concentration of 200 μg/
mL with the highest percentage of inhibition recorded
only at 15 and 17 %, respectively (Table 5).
In vivo hepatoprotective activity
Effect of PEBP, EABP and AQBP on the rats’ liver/
body weight ratio after induction with PCM A signifi-
cant (P < 0.05) augmentation of body weight was ob-
served in the group that received PCM following pre-
treatment with 10 % DMSO when compared to the nor-
mal control group. Only EABP and AQBP, at the con-
centration of 250 and 500 mg/kg, caused significant (P <
0.05) decreased in body weight (Table 6). With regard to
the liver/body weight ratio, only EABP, at the dose of
500 mg/kg, caused significant (P < 0.05) decrease in the
liver/body weight ratio. In comparison, 200 mg/kg sily-
marin also caused a significant (P < 0.05) reduction in
the body weight and liver/body weight ratio in compari-
son to the hepatotoxic group (Table 6).
Histopathological study
Histopathological study was performed on the liver to
observe any deformities in the structure. The group pre-
treated with 10 % DMSO (normal) without PCM intoxi-
cation presented normal hepatic cells with well-
preserved cell structure (Fig. 1a). The group pre-treated
with 10 % DMSO followed by PCM administration had
infiltration of lymphocytes and massive necrosis of the
perivenular and midzonal regions (Fig. 1b). In the
PEBP–pre-treated group, the pathological changes to the
liver were not significantly different between groups that
received various doses of PEBP, in which the liver mostly
had moderate necrosis and moderate inflammation
(Fig. 1d-f ). Groups treated with 250 and 500 mg/kg
EABP presented mild necrotic regions and mild inflam-
mation in comparison to the group treated with 50 mg/
kg EABP that showed moderate necrosis (Fig. 1g-i).
Meanwhile, the group pre-treated with 50 mg/kg AQBP
demonstrated moderate necrosis and inflammation that
tend to improve remarkably leaving only mild inflamma-
tion at the centrilobular zone after pre-treatment with
the 500 mg/kg AQBP (Fig. 1j-l). Administration of
200 mg/kg silymarin reversed the PCM-induced intoxi-
cation (Fig. 1c).
Biochemical study
PCM administration significantly (P < 0.05) increased
serum ALT, AST, ALP levels in the group pre-treated
with 10 % DMSO when compared to the normal non–
PCM-intoxicated group (Table 8). From the results ob-
tained, only EABP significantly (P < 0.05) reduced the el-
evated serum ALT level, at all doses tested, followed by
AQBP and PEBP. Meanwhile, EABP followed by PEBP
and AQBP significantly (P < 0.05) reduced the elevated
serum AST level but did not affect the serum ALP level
value. In comparison, silymarin (200 mg/kg) exhibited
the ability to counteract the toxic effect of PCM by sig-
nificantly (P < 0.05) decreasing the level of all liver en-
zymes in comparison to the PCM-intoxicated group
(Table 8).
In addition, PCM-intoxicated rats demonstrated sig-
nificant (P < 0.05) decreased in the serum level of TP but
increased in the serum level of LDH when compared to
the normal non–PCM-intoxicated group (Table 9).
Interestingly, all partitions, at all doses tested, signifi-
cantly (P < 0.05) reversed the toxic effect of PCM while
increasing the level of TP in a dose-independent man-
ner. Meanwhile, all partitions, at all doses tested, signifi-
cantly (P < 0.05) decreased the serum level of LDH also
in a dose-independent manner (Table 9).
Phytochemical screening of PEBP, EABP and AQBP
Phytochemical constituents of PEBP, EABP and AQBP
are shown in Table 10. PEBP was found to contain flavo-
noids, condensed tannins, triterpenes and steroids;
EABP was found to contain saponins, flavonoids, con-
densed tannins and steroids, and; AQBP was found to
contain only saponins.
Table 3 Superoxide scavenging activity of different extracts
Sample Superoxide scavenging (%)
PEBP 62.20 ± 3.55
EABP 88.30 ± 5.25
AQBP 44.7 ± 3.15
The data are expressed as the percentage of free radical scavenging activity
All values are expressed as mean ± SEM
Note: H, high (71–100 %); M, moderate (41–70 %); L, low (0–40 %); NA,
not active
Table 4 Oxygen radical absorbance capacity of different
extracts




The ORAC values are expressed in micromoles of Trolox Equivalents per 100 g
of samples
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HPLC Profile of PEBP, EABP and AQBP
The HPLC profiles of PEBP, EABP, and AQBP were
measured at the wavelengths of 210, 254, 280, 300, 330,
and 366 nm. Clear peak separation was detected at dif-
ferent wavelengths. For PEBP, 2 major peaks were clearly
separated at the wavelengths of 254 and 330 nm in the
chromatogram at the respective RT of 26.8 and 29.4 min
(P1 and P2). The λmax values of the peaks were at 273.2
and 332.1 nm, respectively (Fig. 2).
The HPLC profile of EABP showed the isolation of 6
major peaks (P1, P2 P3, P4, P5, and P6) at different
wavelengths in the chromatogram (Fig. 3) at the respect-
ive RT of 16.91 min (254 nm), 27.69 min (300 nm),
21.50 min (330 nm), and 17.93, 19.20, and 19.83 min
(366 nm). Further analysis found that all peaks had λmax
values in the region of 214.3, 285.1–319.5, 230.7–323.1,
255.5–352.9, 264.9–343.4, and 254.3–350.6 nm, respect-
ively (Fig. 3).
Meanwhile, HPLC of AQBP demonstrated the isola-
tion of 7 peaks at different wavelengths in the
chromatogram (P1, P2 P3, P4, P5, P6, and P7) at the re-
spective RT of 7.75 min (210 nm), 3.69 min (254 nm),
15.18 min (330 nm), and 17.90, 18.70, 19.15, and
19.86 min (366 nm), respectively. The peaks were fur-
ther analyzed, showing λmax values in the region of
250.8–330.3, 270.8–354.1, 208.4–310.0, 255.5–349.4,
235.4–330.3, 233.1–254.9, and 254.3–349.4 nm, respect-
ively (Fig. 4).
Discussion
PCM is safe when consumed in therapeutic doses; inter-
action with other drugs and side effects are rarely ob-
served [29]. However, overdose of PCM is known to
result in liver injury, with the potential for liver failure
progression [30, 31]. Given its clinical relevance, PCM is
a widely preferred toxicity model for the evaluation of
hepatoprotective agents [29]. Via the glucuronidation
process, more than 90 % of PCM that has been con-
sumed in therapeutic doses is conjugated by the liver
into inactive components, non-toxic sulphate, and glu-
curonide prior to their excretion in the urine. Mean-
while, less than 5 % of PCM is metabolized to a highly
reactive toxic metabolite: N-acetyl-p-benzoquinoneimine
(NAPQI), via CYP450 [32]. NAPQI is commonly re-
duced by glutathione (GSH) to a non-toxic mercaptate
conjugate. GSH has been highlighted as being respon-
sible for the antioxidant defense in humans by scaven-
ging the free radicals produced through the metabolism
processes within the liver [33] in order to prevent subse-
quent cell damage. Excessive intake of PCM causes the
metabolic pathways, particularly the sulphation and glu-
curonidation pathways, to become saturated, resulting in
the shunting of more PCM down the CYP450 pathway
to generate unnecessary high amounts of NAPQI.
Table 5 Effect of extracts on the anti-inflammatory mediators
using the in vitro lipoxygenase and xantine oxidase assays
Sample Lipoxygenase (%) Xanthine oxidase (%)
NDGA (reference
standard of LOX)
99.86 ± 0.14 -
Allopurinol (reference
standard of XO)
- 97.58 ± 0.32
PEBP NA 8.57 ± 0.86
EABP 15.05 ± 2.33 17.05 ± 3.14
AQBP 9.65 ± 1.10 1.65 ± 0.84
All values are expressed as mean ± SEM
Note: H, high (71–100 %); M, moderate (41–70 %); L, low (0–40 %); NA,
not active
Table 6 Effect of PEBP, EABP and AQBP on percentage change of liver weight in PCM- treated rats
Treatment Dose (mg/kg) Change of body weight (%) Liver/body weight ratio (g/100 g)
Normal control - 5.14 ± 0.43 2.86 ± 0.05
10 % DMSO + PCM 17.58 ± 2.10a 4.58 ± 0.33a
Silymarin + PCM 200 3.11 ± 0.67b 3.59 ± 0.10b
PEBP + PCM 50 14.20 ± 1.64 4.24 ± 0.14
250 14.69 ± 2.60 4.20 ± 0.32
500 15.84 ± 1.34 3.82 ± 0.05a
EABP + PCM 50 15.20 ± 1.07 4.53 ± 0.32
250 3.72 ± 1.10b 4.62 ± 0.17
500 4.01 ± 0.98b 3.95 ± 0.19a
AQBP + PCM 50 9.78 ± 1.13b 4.16 ± 0.11
250 8.26 ± 0.91b 4.39 ± 0.21
500 14.26 ± 1.76 4.18 ± 0.25
Values are expressed as means ± S.E.M. of six replicates
a Significant different (p < 0.05) when compared to the normal control group ((10 % DMSO + dH2O)-treated) of the respective column
b Significant different (p < 0.05) when compared to the negative control group ((10 % DMSO + PCM)-treated) of the respective column
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Table 7 Histopathological evaluation of the effects of PEBP, EABP and AQBP against PCM-induced hepatic injury in rats
Treatment Dose (mg/kg) Steatosis Necrosis Inflammation Haemorrhage
Normal control - - - - -
10 % DMSO + PCM - +++ ++ +
Silymarin + PCM 200 - + + -
PEBP + PCM 50 - +++ ++ -
250 - ++ ++ -
500 - ++ ++ -
EABP + PCM 50 - ++ ++ -
250 - + + -
500 - + + -
AQBP + PCM 50 - ++ ++ -
250 - + ++ -
500 - + ++ -
The severity of various features of hepatic injury was evaluated based on those following scoring scheme: − normal, + mild effect, ++ moderate effect, +++
severe effect
Fig. 1 a Normal liver parenchyma, b Section of liver tissue treated with 3 g/kg PCM (p.o) showing massive necrosis, and inflammation. c Section of
liver tissue pre-treated with 200 mg/kg silymarin followed by PCM showing preservation of normal hepatocytes. d Section of liver tissue pre-treated
with 50 mg/kg PEBP followed by PCM showing massive tissue necrosis and mild inflammation. e Section of liver tissue pre-treated with 250 mg/kg
PEBP followed by PCM showing moderate necrosis and mild inflammation. f Section of liver tissue pre-treated with 500 mg/kg PEBP followed by PCM
showing moderate necrosis and inflammation. g Section of liver tissue pre-treated with 50 mg/kg EABP followed by PCM showing moderate necrosis.
h Section of liver tissue pre-treated with 250 mg/kg EABP followed by PCM showing mild necrosis. i Section of liver tissue pre-treated with 500 mg/kg
EABP followed by PCM showing mild inflammation and necrosis. j Section of liver tissue pre-treated with 50 mg/kg AQBP followed by PCM showing
moderate inflammation and necrosis. k Section of liver tissue pre-treated with 250 mg/kg AQBP followed by PCM showing mild necrosis and
inflammation. l Section of liver tissue pre-treated with 500 mg/kg AQBP followed by PCM showing mild inflammation. (H & E, X100). CV) central
vein. N) necrosis. I) inflammation
Zakaria et al. BMC Complementary and Alternative Medicine  (2016) 16:175 Page 8 of 16
Excessive production of NAPQI depletes the GSH stores
in the body [34]. GSH concentrations dropped to low
levels in the centrilobular cells, subsequently affecting
the ability of GSH peroxidase, the major peroxide de-
toxification enzyme, to function efficiently under condi-
tions of GSH deficiency. In the situation when the GSH
supply decreases to less than 30 % of the normal, the un-
bound NAPQI will bind nonspecifically to tissue macro-
molecules, including intracellular proteins, particularly
those with sulfhydryl groups, consequently causing cell
dysfunction and death [32, 35].
Despite the advancement in the field of modern medi-
cine with the development of various types of new drugs
to treat various types of ailments, their effectiveness is
sometimes surpassed by their adverse side effects.
Therefore, researches are being carried out throughout
the world to find alternative drugs with less, or, possibly,
no side effects to help treat those ailments. In the case
of liver toxicity, limited number of drugs has been devel-
oped to help fight this disease, but their uses are usually
accompanied by unwanted side effects. In an attempt to
contribute to the search for potent and safe liver-
protecting agent, the hepatoprotective potential of B.
purpurea was investigated. The reason for choosing B.
purpurea was based on the findings that the plant pos-
sesses remarkable antioxidant and anti-inflammatory activ-
ities [7, 8, 9, 12, 13], which have been generally known to
play part in the mechanisms of hepatoprotection.
In the present study, three types of partitions, namely
PEBP, EABP and AQBP, were prepared from MEBP and
subjected to the PCM-induced liver toxicity in rats’
model. From the results of serum biochemical analysis,
EABP was found to be the most effective partition
followed by the AQBP with PEBP shows no effect on the
liver function enzymes level. Only EABP, at all doses
tested, were able to reduce the serum enzymes’ level,
which was earlier increase by the overdose PCM. This
finding was supported by the microscopic observations
and histopathological scoring. Overall, these observa-
tions suggested that the hepatoprotective activity of B.
purpurea could be due to the synergistic action of a
mixture of polar and non-polar compounds with the
intermediate polarity compounds being the main hepa-
toprotective compounds in B. purpurea. Moreover, the
suggested synergistic action of compounds present in
Table 8 Effect of PEBP, EABP and AQBP on liver function enzymes, ALT, AST and ALP
Treatment Dose (mg/kg) ALT (U/L) AST (U/L) ALP (U/L)
Normal control - 13.1 ± 1.0 89.6 ± 2.5 110.0 ± 6.4
10 % DMSO + PCM 1797.0 ± 141.2a 2970.0 ± 254.0a 338.8 ± 50.7a
Silymarin + PCM 200 517.5 ± 181.1b 535.5 ± 98.8b 201.0 ± 11.8b
PEBP + PCM 50 1844.0 ± 105.1 2158.0 ± 126.8b 371.4 ± 38.9
250 1831.0 ± 199.0 1960.0 ± 131.1b 316.0 ± 30.5
500 1219.0 ± 150.5b 1558.0 ± 74.7b 308.2 ± 20.4
EABP + PCM 50 1036 .0 ± 155.2b 1846.0 ± 189.9b 340.4 ± 58.4
250 519.7 ± 143.4b 1807.0 ± 233.3b 320.0 ± 25.9
500 543.9 ± 184.1b 895.8 ± 238.0b 256.0 ± 36.9
AQBP + PCM 50 1777.0 ± 119.0 2930.0 ± 151.1 338.2 ± 34.0
250 1338.0 ± 147.2b 2017.0 ± 262.1b 329.2 ± 29.2
500 719.3 ± 90.9b 1243.0 ± 190.2b 317.6 ± 31.0
Values are expressed as means ± S.E.M. of six replicates
a Significant different (p < 0.05) when compared to the normal control group ((10 % DMSO + dH2O)-treated) of the respective column
b Significant different (p < 0.05) when compared to the negative control group ((10 % DMSO + PCM)-treated) of the respective column
Table 9 Effect of PEBP, EABP and AQBP on total protein (TP; g/
dL) and LDH (U/L) levels
Treatment Dose (mg/kg) TP (g/dL) LDH (U/L)
Normal control - 64.1 ± 3.8 408.2 ± 60.6
10 % DMSO + PCM 50.4 ± 1.4a 1454.0 ± 255.0a
Silymarin + PCM 200 69.1 ± 2.1b 462.0 ± 59.8b
PEBP + PCM 50 77.5 ± 3.5b 1065.0 ± 127.3
250 65.3 ± 1.4b 371.0 ± 35.7b
500 76.5 ± 2.9b 702.4 ± 90.7b
EABP + PCM 50 88.1 ± 4.1b 765.0 ± 199.9b
250 66.9 ± 0.9b 415.0 ± 103.0b
500 83.9 ± 2.3b 727.8 ± 130.8b
AQBP + PCM 50 68.9 ± 3.8b 689.2 ± 148.8b
250 70.4 ± 2.0b 905.4 ± 65.2b
500 68.2 ± 1.9b 525.2 ± 33.9b
Values are expressed as means ± S.E.M. of six replicates
aSignificant different (p < 0.05) when compared to the normal control group
((10 % DMSO + dH2O)-treated) of the respective column
bSignificant different (p < 0.05) when compared to the negative control group
((dH2O + PCM)-treated) of the respective column
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EABP was further supported by the phytochemical
analysis of EABP that demonstrated the presence of fla-
vonoids, tannins and saponins. These classes of com-
pounds have been reported to exert antioxidant [36, 37,
38] and anti-inflammatory [39 40, 41] activities.
TPC values were influenced by the non-polar to polar
solvent extractions. In this case, the value decreased in
the following order: EABP > AQBP > PEBP. Based on the
solvent polarity chart, ethyl acetate is classified as an
intermediate solvent, hence is able to extract
intermediate-polarity phenolic compounds, while aque-
ous and petroleum ether extract polar and non-polar
compounds, respectively. The present findings were
further supported by Azlim Almey et al. [42], who sug-
gested that higher extraction yields of total extractable
polyphenols and total soluble solids are collected as the
solvent polarity increases. In the present study, although
EABP was considered to have the highest TPC value
(271 mg GAE/100 g extract) in comparison to the other
partitions (PEBP = 105 mg GAE/100 g extract; AEBP =
133 mg GAE/100 g extract), the value was lower than
the standard value (>1000 mg GAE/100 g extract) for
any substances to be considered as having a high TPC
[19]. It is important to highlight that MEBP did possess
a high TPC value of approximately 1218 mg GAE/100 g
extract [14]. Usually, it is anticipated that extracts with a




BP MEBP PEBP EABP AQBP
Alkaloids - - - - -
Saponins + + - + +
Flavonoids + + ++ ++ -
Tannins and polyphenolic
compounds
+ + + + +
Triterpenes +++ + ++ - -
Steroids +++ ++ +++ +++ -
BP - B. purpurea leaves, MEBP - methanol extract of B. purpurea
For saponins - + = 1–2 cm froth; ++ = 2–3 cm froth; +++ = >3 cm froth
For flavonoids, tannins, triterpenes and steroids - + = weak colour; ++ =mild colour; +++ = strong colour
For akalioids - + = negligible amount of precipitate; ++ =mild precipitate; +++ = strong precipitate; – = not detected
Fig. 2 The UV spectra analysis of peak 1 (RT = 26.85 min) and peak 2 (RT = 29.4 min) of the PEBP at 254 nm and 339 nm exhibiting the λ max at
273 nm and 323 nm respectively
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Fig. 3 The UV spectra analysis of peak 3 (RT = 17.93 min), peak 4 (RT = 19.20 min) and peak 5 (RT = 19.83 min) of the EABP at 366 nm exhibiting
the λ max at 256–353 nm, 265–343 nm and 254–351 nm, respectively, suggesting, in part, the presence of flavonoid-based compounds
Fig. 4 The UV spectra analysis of peak 1 (RT = 7.75 min), peak 2 (RT = 3.69 min), and peak 4 (RT = 17.89 min) and peak 7 (RT = 19.83 min) of the
AQBP at 210 nm, 254 nm, and 366 nm respectively. The peaks exhibit the λ max at 251–330 nm, 271–354 nm, 256–349 nm and 254–349 nm,
respectively, suggesting, in part, the presence of flavonoid-based compounds
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high amount of polyphenolic content should also exhibit
high antioxidant activity [43]. However, there is also re-
port on the presence of extract with low TPC value exhi-
biting high antioxidant activity [44], which supported
the presence finding as demonstrated by EABP. Reihani
and Azhar [45], while discussing on their finding that
the curry leaf demonstrated a comparatively low antioxi-
dant activity despite showing the highest TPC value,
cited that the difference could be related to poor specifi-
city of the TPC assay [46, 47]. Moreover, Singleton et al.
[47] also suggested that the phenolic compounds, de-
pending on the number of phenolic groups they have,
react differently to the Folin–Ciocalteu reagent.
In discussing the relationship between TPC value and
antioxidant activity, it is worth to discuss on phenolic
compounds in general. Phenolic compounds, broadly
distributed in the plant kingdom, are the most abundant
secondary metabolites of plants. They are compounds
having one or more aromatic rings with one or more hy-
droxyl groups. Currently, more than 8000 phenolic
structures have been identified, ranging from simple
molecules (i.e. phenolic acids) to incredibly polymerized
substances (i.e. tannins). The most common plant phe-
nolics include phenolics acids, flavonoids, tannins, with
flavonoids being the most plentiful polyphenols in our
diets. Flavonoids are themselves classified into several
subclasses depending on the oxidation state of the cen-
tral C ring. The five well-known subclasses of flavonoids
are flavonols, flavones, flavanones, flavanonols, and dihy-
droflavonols. Their structural dissimilarity in each sub-
group is in part attributable to the degree and pattern of
hydroxylation, methoxylation, prenylation, or glycosyla-
tion [48]. Tannins, another major group of polyphenols,
are usually subdivided into two classes, namely hydrolys-
able tannins and condensed tannins. Hydrolysable tan-
nins are compounds containing a central core of glucose
or another polyol esterified with gallic acid (known as
gallotannins), or with hexahydroxydiphenic acid (known
as ellagitannins). The high diversity in the structure of
these compounds is attributable to the many possibilities
in forming oxidative linkage [49]. On the other hand,
condensed tannins are oligomers or polymers of flavan-3-
ol connected through an interflavan carbon bond. The
structure diversity of this class of tannins can be due to
various factors such as the discrepancy in hydroxylation
pattern, stereochemistry at the three chiral centers,
and the location and type of interflavan linkage, as
well as the degree and pattern of methoxylation, gly-
cosylation and galloylation [50]. The fact that there
are various types of polyphenolic compounds in EABP
might support the claim made by Singleton et al. [47]
that those polyphenolic compounds react differently
to the Foin-Ciocalteu reagent resulting in the low
TPC value obtained.
Polyphenolics, as antioxidants, are believed to have the
capability to donate hydrogen to free radicals, conse-
quently breaking the chain reaction of lipid peroxidation
at the initiation stage [51]. The fact that EABP exerted
high antioxidant activity when assess using the super-
oxide radical scavenging and ORAC assays seems to sug-
gest the presence of high polyphenolic compounds in
EABP. However, this suggestion seems to be contra-
dicted by EABP’s low TPC value indicating that the anti-
oxidant activity did not correlate with the TPC value.
According to Wong et al. [52], since TPC value is ob-
tained following the Folin–Ciocalteu reaction, which is
based on redox reactions, the assay detects not only
polyphenolic compounds, but also other biological sub-
stances that are reactive towards the Folin–Ciocalteu re-
agents (i.e. amino acids, carbohydrates and ascorbic
acid) [46, 47]. It is plausible to suggest that some of the
polyphenolic compounds present in EABP did not work
via redox reaction against the Folin-Ciocalteu reagents
leading to low TPC value. In addition, the low to moder-
ate antioxidant activity observed in the DPPH radical
scavenging assay could be due to the presence of some
polyphenolic compounds that may not scavenge DPPH
radicals (DPPH●) due to steric resistance [52]. Following
the DPPH radical scavenging assay, EABP was also
found to exert the highest antioxidant activity further
suggesting the parallel relationship between total phen-
olic value and antioxidant activity. In the SOD scaven-
ging assay, EABP again demonstrated potential free
radical scavenging activity. The ability of EABP to effect-
ively attenuate both assays suggests its potential to work
via the mechanism of reduction. Interestingly, EABP and
AQBP were also able to exert remarkable antioxidant ac-
tivity when measured using the ORAC assay, which is
based on the peroxyl radical absorbance capacity of an
extract [53]. Based on all of the above analysis, EABP is
believed to have promising antioxidant activity followed
by AQBP and PEBP.
Following subjection to the in vitro LOX and XO as-
says, all partitions of MEBP were found to exert very
low anti-inflammatory activity. LOXs are enzymes that
have a major role in manipulating the biosynthesis of
leukotrienes, which have been ascribed to the patho-
physiology of several allergic and inflammatory diseases
[54]. Meanwhile, XO is important for catalyzing the se-
quential oxidation of hypoxanthine to xanthine, and to
the production of hydrogen peroxide and uric acid [55].
The enzymatic activity via the LOX and XO pathways
essentially involve modulation of the inflammation
mechanism [56, 57]. Although the present anti-
inflammatory findings might be in contrast to previous
anti-inflammatory report on B. purpurea [15], several
factors are to be considered. Firstly, the type of inflam-
matory models used to evaluate the anti-inflammatory
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potential of extract and partitions were significantly dif-
ferent, wherein assessment of the earlier was made using
in vivo models whereas assessment of the latter was
made using the in vitro models. Moreover, the in vivo
models used were more related to the cyclo-oxygenase
(COX)-dependent model [15]. COX plays a major role
in catalyzing the production of prostaglandin [58]. The
role of COX and prostaglandin in the modulation of B.
purpurea pharmacological action could be justified by
the ability of MEBP to exert antiulcer activity. As dis-
cussed by Zakaria et al. [9] and Abdul Hisam et al. [59],
the aqueous (AEBP) or chloroform (CEBP) extracts of B.
purpurea exert antiulcer activity via a local and non-
specific mechanism known as cytoprotection. It is
claimed that cytoprotection take place as a result of the
ability of certain compounds to trigger the synthesis of
prostaglandin, which consecutively lead to the synthesis
of mucus and bicarbonate. Thus, from the results ob-
tained it is plausible to suggest that the anti-
inflammatory property of B. purpurea that may contrib-
ute to the hepatoprotective activity of EABP or AEBP
occur via the non-LOX, non-XO-, but COX-mediated
pathway.
The presence of hepatoprotective activity in B. pur-
purea, particularly its methanol extract (MEBP) and par-
titions (EABP and AQBP), could be attributed to the
presence of various phytoconstituents in the extract and
its partitions. Flavonoids, tannins, saponins and triter-
penes have been reported elsewhere to exert various
pharmacological activities including hepatoprotective ac-
tivity [40, 60, 61, 62]. Although the presence of other
classes of compounds should not be ignored, the pres-
ence of flavonoids in the partition, particularly, will be
highlighted in this discussion based on the HPLC find-
ings. The presence of flavonoids in B. purpurea has been
reported earlier by Yadav and Bhadoria [63], supported
the presence of flavonoids in MEBP or its partitions,
namely EABP and PEBP, as demonstrated by the phyto-
chemical screening data. This claimed was further
strengthen by the recent HPLC findings, which show
that the detected peaks fall within the UV-Vis spectra
(λmax) of flavonoid-type compounds [64]. According to
Tsimogiannis et al. [64], flavonoids are categorized into
five major subgroups: flavonols, flavones, flavanones, fla-
vanonols, and dihydroflavonols. There are 2 absorbance
bands on the UV-Vis spectra for determination of fla-
vonoid types wherein for flavonols or flavones the spec-
tra that fall in the respective region of 350–385 nm or
310–350 nm was labeled band A while for band B the
spectra lies in the region of 250–290 nm. EABP had 3
major peaks detected from different wavelengths with
λmax at 256–353 nm (Fig. 3), and the 4 major peaks of
AQBP were detected at 251–354 nm (Fig. 4). Referring
to the chromatogram of the extracts, the major peaks
that fell in the region mentioned by Tsimogiannis et al.
[64] are apparently flavonoid-based compounds. The
most outstanding properties of almost all groups of fla-
vonoids is how they act as antioxidant [65, 66] and anti-
inflammatory [67, 68] agents. The ability of EABP to
exert the most effective hepatoprotective activity could
be linked partly to the presence of flavonoid-based com-
pounds, which might act as antioxidant and COX-
modulated anti-inflammatory agents as discussed above.
Other than the types of polyphenolic compounds dis-
cussed above, it is also important to highlight on the
presence of complex polyphenolic compounds such as
those that form dimeric flavonoids or those that form a
complex with carbohydrate or protein [69]. Focusing on
the leaves of B. purpurea, our literature search demon-
strated that the bioactive compounds identified from the
leaves were not single pure polyphenolic compounds but
rather dimeric flavonoids of which one of them were as-
sociated with carbohydrates, namely bis [3’,4’-dihydroxy-
6-methoxy-7,8-furano-5’,6’-mono methylalloxy]-5-C-5-
biflavonyl and (4’-hydroxy-7-methyl 3-C-α-L-rhamno-
pyranosyl)-5-C-5-(4’-hydroxy-7-methyl-3-C-α-D-gluco-
pyranosyl) bioflavonoid [70]. The presence of a complex
polyphenolic compounds might explained why there is
no match of HPLC peaks when comparison were made
between the HPLC chromatogram of MEBP or EABP
against several pure flavonoids (i.e. fisetin, quercetin,
rutin, quercitrin, naringenin, genistein, pinostrobin,
hesperetin, dihydroquercetin, flavanone, 4’.5’7’-trihy-
droxy flavanone) (data not shown), thus, suggesting that
the flavonoids present in MEBP and EABP are not pure
polyphenolic compound(s) but rather a complex poly-
phenolic compounds as described above.
Conclusion
Based on the above data, it is concluded that the EABP
demonstrated the most effective hepatoprotective activ-
ity against the PCM-induced liver intoxication in rats in
the order of EABP>AQBP>PEBP. The hepatoprotective
mechanism of EABP could be linked to its antioxidant
activity, possibly via the radical scavenging activity. How-
ever, the antioxidant activity of EABP did not correlate
with its polyphenolic content. Although EABP only
demonstrated low anti-inflammatory activity via the
LOX- and XO-mediated inflammation, the ability of
EABP to exert anti-inflammatory activity via COX-
modulated pathway should not be disregarded based on
the previous reports that B. purpurea leaves extracts
possessed anti-inflammatory activity against the COX-
mediated inflammatory models. The hepatoprotective
and antioxidant activities of EABP, which were inde-
pendent of its low TPC value, could also be linked to
the presence of several flavonoid-based bioactive com-
pounds. The presence of flavonoid-based compounds
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partly in EABP were proposed based on two reasons: i)
the analysis of each peak obtained from HPLC study re-
vealed that the wavelength fall within the range that re-
flects flavonoid-based bioactive compounds, and ii) the
phytoconstituents screening of EABP demonstrated in
part the presence of flavonoid-based compounds.
Moreover, these flavonoids might synergistically act
with several saponins and tannins, detected during
the phytocontituents screening, to exert the hepato-
protective and antioxidant activities. These results
support the medicinal value of B. purpurea in general
and may suggest the therapeutic potential of EABP, in
particular, for the treatment of inflammatory disease,
including liver injury.
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